Casak, S. J. (2018). FDA's Approval of the First Biosimilar to Bevacizumab. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationCasak, S. J. FDA's Approval of the First Biosimilar to Bevacizumab. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationCasak, S. J. FDA's Approval of the First Biosimilar to Bevacizumab. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.